Intrauterine Cannabis Exposure Tied To Adverse Birth Outcomes
- byDoctor News Daily Team
- 14 July, 2025
- 0 Comments
- 0 Mins
Canada: A recent study in Addiction revealed an association between prenatal cannabis use and lower birth weight, neonatal ICU (NICU) admission in newborns, and preterm births. However, cannabis-exposed infants are not at greater risk of birth defects or death within one year, including sudden unexpected infant death.
"There is little evidence that prenatal cannabis exposure adversely affects cognitive or behavioural outcomes in early childhood, with the exception of attention and externalizing problems," the researchers wrote in their study.
First author Ms. Maryam Sorkhou comments, “The global increase in cannabis use among women of reproductive age also extends to pregnant women. We know that THC, the main psychoactive constituent in cannabis, can cross the placenta from mother to fetus and bind to receptors in the fetal brain.
Our study adds to that knowledge by showing that prenatal exposure to cannabis heightens the risk of several adverse birth outcomes.”
This meta-analysis (a synthesis of past studies) pooled the results of 57 prior studies with a total of 12,901,376 infant participants, 102,835 of them exposed to cannabis.
Twenty of the studies measured the association between intrauterine cannabis exposure and risk of preterm delivery. In these, the combined results show that mothers using cannabis were over one and a half times more likely to have a preterm delivery compared with mothers not using cannabis during pregnancy.
Eighteen of the studies measured the risk of low birth weight. In these, the combined results show that mothers using cannabis during pregnancy were more than twice as likely to have a low-birth-weight baby compared with mothers not using cannabis during pregnancy.
Ten of the studies measured the risk of requiring NICU admission. In these, the combined results show that newborns with intrauterine cannabis exposure were more than twice as likely to require NICU admission than nonexposed newborns.
The studies included in this meta-analysis were published between 1984 and 2023 in a broad range of countries.
References: Maryam Sorkhou, Daisy R. Singla, David J. Castle, Tony P. George First published: 15 November 2023 https://doi.org/10.1111/add.16370
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
DME Gujarat extends PG Ayurveda, Homeopathy round...
- 05 November, 2025
NEET counselling: CENTAC publishes round 3 provisi...
- 05 November, 2025
Marksans Pharma UK arm gets marketing nod for Exem...
- 05 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!